Cancer BiologyLife Science AlliancePeer-reviewed
Development of a pipeline to evaluate YAP-TEAD inhibitor potential - direct TEAD inhibition represses cancerous growth in a NF2-mutant model of mesothelioma
Richard Cunningham, Siyang Jia, Krishna Pinganksha Purohit…·Carsten Gram Hansen
The paper develops a pipeline to compare YAP/TAZ-TEAD inhibitors in mesothelioma models, identifying genetic compensation and off-target effects.
10 citationstop 4%